ConvaTec Shares Drop Again as Wound-Care Warning Puts 2026 Growth Plan in Focus
Convatec Group Plc dropped in London trading on Friday, putting the FTSE 100 medical-products company back in the spotlight. Investors are now sizing up its 2026 growth ambitions, with new signals of weakness emerging in certain segments of the wound-care market. Convatec shares finished the day at £2.21, down 1.69%—a steeper drop than the broader market. The closing price, according to MarketWatch, leaves the stock trading 29.05% beneath its 52-week high of £3.11.